FTH1 Gene — Ferritin Heavy Chain 1

FTH1 Gene — Ferritin Heavy Chain 1

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#1976D2; color:white;">FTH1</th></tr>
<tr><td><strong>Full Name</strong></td><td>Ferritin Heavy Chain 1</td></tr>
<tr><td><strong>Gene Symbol</strong></td><td>FTH1</td></tr>
<tr><td><strong>Chromosomal Location</strong></td><td>19q13.33</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>2495</td></tr>
<tr><td><strong>OMIM ID</strong></td><td>134790</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000196950</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>P02794</td></tr>
<tr><td><strong>Protein Family</strong></td><td>Ferritin heavy chain subunit</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>Neuroferritinopathy, Alzheimer's Disease, Parkinson's Disease, NBIA, ALS</td></tr>
</table>
</div>

Introduction

FTH1 encodes the ferritin heavy chain 1 (FTH1), the catalytic subunit of the ferritin protein complex. While FTL (ferritin light chain) provides structural stability and iron nucleation, FTH1 contains the critical ferroxidase center that catalyzes the conversion of toxic Fe²⁺ (ferrous iron) to Fe³⁺ (ferric iron) for safe storage within the ferritin shell[@levi2014]. This enzymatic activity is essential for cellular protection against iron-mediated oxidative damage.

FTH1 Gene — Ferritin Heavy Chain 1

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#1976D2; color:white;">FTH1</th></tr>
<tr><td><strong>Full Name</strong></td><td>Ferritin Heavy Chain 1</td></tr>
<tr><td><strong>Gene Symbol</strong></td><td>FTH1</td></tr>
<tr><td><strong>Chromosomal Location</strong></td><td>19q13.33</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>2495</td></tr>
<tr><td><strong>OMIM ID</strong></td><td>134790</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000196950</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>P02794</td></tr>
<tr><td><strong>Protein Family</strong></td><td>Ferritin heavy chain subunit</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>Neuroferritinopathy, Alzheimer's Disease, Parkinson's Disease, NBIA, ALS</td></tr>
</table>
</div>

Introduction

FTH1 encodes the ferritin heavy chain 1 (FTH1), the catalytic subunit of the ferritin protein complex. While FTL (ferritin light chain) provides structural stability and iron nucleation, FTH1 contains the critical ferroxidase center that catalyzes the conversion of toxic Fe²⁺ (ferrous iron) to Fe³⁺ (ferric iron) for safe storage within the ferritin shell[@levi2014]. This enzymatic activity is essential for cellular protection against iron-mediated oxidative damage.

The ferritin complex is composed of 24 subunits (a heteropolymer of heavy and light chains) capable of storing up to 4,500 iron atoms. FTH1 is ubiquitously expressed and is particularly important in the brain, where iron dysregulation is a hallmark of multiple neurodegenerative diseases including Alzheimer's disease (AD), Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS)[@ward2014].

This comprehensive overview addresses the structure, function, and disease associations of FTH1, with particular emphasis on its emerging role in neurodegeneration and therapeutic implications.

Gene Structure and Evolution

Genomic Organization

The FTH1 gene is located on chromosome 19q13.33, in close proximity to FTL. This genomic organization reflects the evolutionary relationship between the two ferritin subunits.

Key genomic features:

• Chromosomal location: 19q13.33
• Exon count: 4 exons
• Promoter: Contains Iron Response Elements (IREs) for translational regulation
• Tissue-specific expression: High in brain, liver, spleen

Protein Structure and Biochemistry

FTH1 combines with FTL to form the functional ferritin heteropolymer:

Structural features[@levi2014]:

• Ferroxidase center: Located in FTH1, catalyzes Fe2+ -> Fe3+ oxidation
• Heteropolymer formation: 12 FTH1 + 12 FTL (optimal ratio varies by tissue)
• Hollow shell: 12-nm diameter cavity for iron storage
• Channel architecture: 8 three-fold and 6 four-fold channels for iron entry/exit
• Iron oxidation: Fe2+ + O2 + 2H2O -> Fe3+ + H2O2 (ferroxidase reaction)

Molecular Function

Iron Storage and Homeostasis

FTH1 plays a central role in cellular iron homeostasis:

Iron sequestration:

• Stores up to 4,500 iron atoms per ferritin molecule
• Catalyzes iron oxidation through ferroxidase activity
• Prevents Fenton reaction-mediated oxidative damage

• Site A (ferroxidase center) in FTH1 catalyzes Fe²⁺ oxidation
• Critical for preventing hydroxyl radical formation
• Rate-limiting step in iron core formation

Antioxidant Defense

Ferritin serves as a crucial antioxidant buffer:

• Sequesters free iron that would otherwise generate ROS
• Upregulated under oxidative stress conditions
• Protects against ferroptosis (iron-dependent cell death)[@yang2016]

Ferritinophagy

The autophagic degradation of ferritin, termed ferritinophagy, is regulated by NCOA4:

Mechanism[@khan2019][@gomez2022]:

• NCOA4 binds ferritin and delivers it to lysosomes
• Iron released during degradation supports cellular needs
• Dysregulated ferritinophagy contributes to iron dysregulation in disease

Role in Neurodegenerative Diseases

Alzheimer's Disease

FTH1 is implicated in AD pathogenesis through iron dysregulation[@chen2020]:

Amyloid-iron relationship:

• Ferritin found in amyloid plaques
• Iron promotes amyloid-beta aggregation
• Iron dysregulation enhances oxidative stress

• Iron chelation approaches in clinical trials
• Ferritin expression modulation as potential therapy

Parkinson's Disease

FTH1 plays critical roles in PD pathogenesis[@baksi2017][@angelova2019]:

Dopaminergic neuron vulnerability:

• High iron in substantia nigra
• Ferritin expression changes in PD brains
• Iron-induced oxidative stress in dopaminergic neurons

• Iron promotes alpha-synuclein aggregation
• Ferritin may modulate alpha-synuclein toxicity
• NCOA4-mediated ferritinophagy affected in PD

Amyotrophic Lateral Sclerosis

Iron accumulation is observed in ALS, with FTH1 potentially involved[@chio2019]:

• Elevated iron in motor cortex
• Ferritin changes in ALS models
• Iron dysregulation contributes to motor neuron degeneration

Neurodegeneration with Brain Iron Accumulation

While FTL mutations cause neuroferritinopathy, FTH1 is also relevant to NBIA disorders:

• FTH1 expression changes in NBIA
• Iron accumulation in basal ganglia
• Therapeutic targeting of iron pathways

Expression Pattern

Brain Region Distribution

FTH1 is expressed throughout the brain, with highest levels in iron-rich regions[@zecca2004]:

| Brain Region | Expression Level | Cell Types |
|--------------|------------------|------------|
| Substantia nigra | Very high | Dopaminergic neurons |
| Basal ganglia | Very high | Neurons, glia |
| Cerebellum | High | Purkinje cells |
| Cerebral cortex | Moderate | Pyramidal neurons |
| Hippocampus | Moderate | CA neurons |

Cellular Localization

• Neurons: High expression, particularly in substantia nigra
• Oligodendrocytes: High (myelin production requires iron)
• Microglia: Moderate, increases with activation
• Astrocytes: Moderate

Therapeutic Implications

Current Treatment Strategies

Management of ferritin-related neurodegeneration includes[@sawicka2024]:

Iron chelation therapy:
| Drug | Mechanism | Status |
|------|-----------|--------|
| Deferoxamine | Iron chelation | Clinical use |
| Deferasirox | Oral iron chelation | Clinical use |
| Deferiprone | Brain-penetrant | Research |

Antioxidant approaches:

• Coenzyme Q10
• Vitamin E
• Ferroptosis inhibitors

Emerging Therapies

Ferritin modulation[@oriol2019]:

• Small molecules targeting ferritin expression
• NCOA4 modulators for ferritinophagy
• Gene therapy approaches

Animal Models

Genetic Models

• Fth1 knockout: Embryonic lethal (essential for development)
• Conditional knockouts: Brain-specific phenotypes
• Transgenic overexpression: Protection against oxidative stress

Summary

FTH1 encodes ferritin heavy chain 1, the catalytic subunit of ferritin essential for iron storage and cellular protection against oxidative damage. Through its ferroxidase activity, FTH1 converts toxic Fe²⁺ to Fe³⁺ for safe storage within the ferritin shell, preventing iron-mediated ROS generation.

Beyond its fundamental role in iron homeostasis, FTH1 is increasingly recognized as an important factor in common neurodegenerative diseases. Iron dysregulation, altered ferritin expression, and impaired ferritinophagy all contribute to disease pathogenesis in AD, PD, and ALS.

Therapeutic strategies targeting FTH1 and iron homeostasis include iron chelation, antioxidant therapy, and emerging approaches targeting ferritinophagy. Understanding FTH1 function in neurodegeneration continues to inform therapeutic development.

Molecular Mechanisms in Detail

Iron Response Elements and Translational Regulation

FTH1 expression is tightly regulated at the translational level through Iron Response Elements (IREs)[@connor1992]:

IRE-mediated regulation:

• 5'-UTR IREs control translation in response to cellular iron
• IRP (Iron Regulatory Protein) binding blocks translation when iron is low
• Iron binding to IRP releases it from IRE, allowing translation

• Ferritin translation increases with elevated cellular iron
• Protects against iron overload and oxidative damage
• Rapid response to changing iron conditions

Ferroxidase Activity and Catalytic Mechanism

The ferroxidase center in FTH1 catalyzes iron oxidation:

Reaction mechanism:

Kinetic parameters:

• Ferroxidase activity is rate-limiting for iron storage
• Optimal pH ~6.5 for catalytic activity
• Temperature-dependent enzyme kinetics

Clinical Relevance

Biomarker Potential

FTH1 and ferritin have significant biomarker potential[@angelova2019]:

| Sample | Biomarker | Utility |
|--------|----------|---------|
| CSF | Ferritin levels | Iron dysregulation in brain |
| Serum | Ferritin | Systemic inflammation/iron status |
| MRI | QSM | Brain iron accumulation |
| Blood | FTH1 mRNA | Disease progression |

Genetic Associations

FTH1 polymorphisms have been studied in neurodegenerative diseases:

• Modest associations with PD risk
• Possible modification of AD progression
• Interaction with other iron metabolism genes

Interaction Network

Protein Interactions

FTH1 interacts with multiple cellular proteins:

• FTL: Forms heteropolymer ferritin complex
• NCOA4: Mediates ferritinophagy
• IRP1/IRP2: Iron regulatory proteins
• HIF1α: Hypoxia-inducible factor

Signaling Pathways

FTH1 is involved in multiple pathways:

• Iron homeostasis signaling
• Oxidative stress response
• Ferroptosis regulation
• Inflammation modulation

Evolutionary Context

Conservation

FTH1 is highly conserved across species:

| Species | Identity | Notes |
|---------|----------|-------|
| Human | Reference | Full function |
| Mouse | 98% | Single AA difference |
| Zebrafish | 85% | Functional |
| Drosophila | 75% | Single ferritin gene |
| C. elegans | 70% | Different regulation |

Gene Family

The ferritin gene family includes:

• FTH1: Heavy chain, ferroxidase activity
• FTL: Light chain, structural stability
• FTHL: Additional ferritin-like genes

Research Directions

Key Questions

Emerging Approaches

• Small molecule ferroxidase modulators
• Gene therapy for FTH1 delivery
• NCOA4-targeted approaches for ferritinophagy
• Iron chelation with brain-penetrant drugs

Animal Models of FTH1 Dysfunction

Knockout Models

• Fth1 knockout: Embryonic lethal due to anemia
• Conditional brain knockout: Iron accumulation, oxidative stress
• Behavioral phenotypes under development

Transgenic Models

• FTH1 overexpression: Protection against oxidative stress
• Mutant FTH1: Disease modeling
• Humanized models for therapy testing

FTH1 in Specific Brain Regions

Substantia Nigra

FTH1 is highly expressed in dopaminergic neurons:

• Protects against iron-induced oxidative stress
• High baseline expression reflects high iron needs
• Vulnerability in PD related to iron dysregulation

Hippocampus

FTH1 supports cognitive function:

• High expression in CA neurons
• Role in synaptic plasticity
• Implications for AD memory impairment

Basal Ganglia

FTH1 in motor control regions:

• Iron accumulation in NBIA disorders
• Movement disorder phenotypes
• Therapeutic target for iron chelation

Ferritin Complex Formation

Heteropolymer Assembly

The 24-subunit ferritin shell assembles from FTH1 and FTL:

Assembly process:

Functional implications:

• FTH1/FTL ratio affects ferroxidase activity
• Tissue-specific ratios optimize function
• Disease mutations affect assembly

Conclusion

FTH1 represents a critical node in cellular iron homeostasis with profound implications for neurodegeneration. Its ferroxidase activity, expression pattern, and disease associations make it an important therapeutic target. Ongoing research continues to reveal new aspects of FTH1 function and potential intervention points for neurodegenerative diseases.

See Also

• [FTL Gene](/genes/ftl) — Ferritin Light Chain
• [Neurodegeneration with Brain Iron Accumulation (NBIA)](/diseases/nbia)
• [Iron Homeostasis in Neurodegeneration](/mechanisms/iron-homeostasis)
• [Ferroptosis](/mechanisms/ferroptosis)
• [Oxidative Stress Pathway](/mechanisms/oxidative-stress)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Substantia Nigra](/brain-regions/substantia-nigra)
• [Basal Ganglia](/brain-regions/basal-ganglia)

External Links

• [NCBI Gene: FTH1](https://www.ncbi.nlm.nih.gov/gene/2495)
• [UniProt: FTH1](https://www.uniprot.org/uniprot/P02794)
• [Ensembl: FTH1](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000196950)
• [OMIM: FTH1](https://omim.org/entry/134790)

Pathway Diagram

The following diagram shows the key molecular relationships involving FTH1 Gene — Ferritin Heavy Chain 1 discovered through SciDEX knowledge graph analysis: